PerCP/Cyanine5.5 anti-mouse CD64 (FcγRI) Ant

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 ?g per million cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

* PerCP/Cyanine5.5 has a maximum absorption of 482 nm and a maximum emission of 690 nm.

The X54-5/7.1 antibody reacts with mouse strains carrying CD64a and b alleles but not CD64d. X54-5/7.1 recognizes a conformational determinant formed between domains 2 and 3. Additional reported application (for relevant formats) include: immunoprecipitation¹, and spatial biology (IBEX)^5,6. Clone X54-5/7.1 is not found to be useful for Western blots¹.

BioLegend is in the process of converting the name PerCP/Cy5.5 to PerCP/Cyanine5.5. The dye molecule remains the same, so you should expect the same quality and performance from our PerCP/Cyanine5.5 products. Contact Technical Service if you have any questions.

1. Tan PS, et al. 2003. J. Immunol. 170:2549. (IP)
2. Ingersoll MA, et al. 2010. Blood 115:e10. (FC)
3. Ozeri E, et al. 2012. J. Immunol. 189:146. PubMed
4. Richardson ML, et al. 2014. PLoS Negl Trop Dis. 8:2825. PubMed
5. Radtke　AJ,　et al.　2020.　Proc Natl Acad Sci U S A.　117:33455-65. (SB)　PubMed
6. Radtke　AJ,　et al.　2022.　Nat Protoc.　17:378-401. (SB)　PubMed

1. Gogoi H, et al. 2020. Front Immunol. 1.620833333. PubMed
2. van Wijck Y, et al. 2018. J Immunol. 200:1570. PubMed
3. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
4. Pisu D, et al. 2020. STAR Protoc. 1:100123. PubMed
5. De Schepper S et al. 2018. Cell. 175(2):400-415 . PubMed
6. Dodagatta-Marri E, et al. 2021. Cell Rep. 36:109309. PubMed
7. Marinaik CB, et al. 2020. Cell Rep Med. 1:100095. PubMed
8. Baasch S, et al. 2021. Cell. . PubMed
9. Linehan JL et al. 2018. Cell. 172(4):784-796 . PubMed
10. Hubbard JJ, et al. 2020. J Exp Med. :217. PubMed
11. Ahadome S, et al. 2016. JCI Insight. 1:e87012. PubMed
12. Yadava K et al. 2019. Elife. 8 pii: e44821. PubMed
13. Toomey CB, et al. 2018. Invest Ophthalmol Vis Sci. 59:662. PubMed
14. Lee L, et al. 2016. PLoS One. 11:e0167693. PubMed
15. Pisu D, et al. 2020. Cell Rep. 30:335. PubMed
16. Mossadegh–Keller N, et al. 2019. Bio Protoc. 9:5. PubMed
17. Lee W, et al. 2021. J Virol. 95:e0053021. PubMed
18. Mansouri S, et al. 2020. Mucosal Immunol. 0.954861111. PubMed
19. Shibata T, et al. 2020. J Clin Invest. 130:3021. PubMed
20. Kolter J, et al. 2020. Immunity. 50(6):1482-1497. PubMed
21. Sung PS, et al. 2022. JCI Insight. :. PubMed
22. Heinen A, et al. 2019. Mol Ther. 27:46:00. PubMed
23. Hakim R, et al. 2021. J Neurosci. 41:8441. PubMed
24. Feuerstein R, et al. 2015. J Immunol. 194:2735. PubMed
25. Kolter J, et al. 2016. J Immunol. 196: 2733 - 2741. PubMed
26. Yang C, et al. 2019. J Transl Med. 1.004166667. PubMed
27. Subramanian S, et al. 2022. Nat Immunol. 23:458. PubMed
28. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
29. Ge Y, et al. 2020. Mucosal Immunol. 13:34. PubMed
30. Huang WC, et al. 2019. Int J Hyperthermia. 36:1255. PubMed

Monocytes, macrophages, mast cells, dendritic cells